Clinical Laserthermia Systems AB (publ) (FRA:LS60)

Market Cap	5.01M -70.3%
Revenue (ttm)	1.13M -47.4%
Net Income	-3.57M
EPS	-0.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.1070
Previous Close	0.1076
Day's Range	0.1070 - 0.1070
52-Week Range	0.1052 - 0.9070
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About FRA:LS60

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. The co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 13
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LS60

Financial Performance

In 2025, FRA:LS60's revenue was 17.49 million, a decrease of -6.90% compared to the previous year's 18.78 million. Losses were -41.61 million, -12.62% less than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error